1 / 55

Outline

Clostridium difficile : Clean Differently Infection control measures to prevent transmission in inpatient settings. Outline. C. d ifficile overview Pathogenesis Brief description of various tests Transmission of C. difficile Identifying high-touch surfaces

aizza
Download Presentation

Outline

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clostridium difficile: Clean DifferentlyInfection control measures to prevent transmission in inpatient settings

  2. Outline • C. difficileoverview • Pathogenesis • Brief description of various tests • Transmission of C. difficile • Identifying high-touch surfaces • Daily cleaning vs. terminal cleaning • Proper use of bleach • Brief intro to alternative cleaning products

  3. Historical Perspective • Bacillus difficilis(now C. difficile) was cultured from healthy neonates in 1935 • In the 1960’s it was noted that patients on antibiotics developed diarrhea • “Staphylococcal Colitis” • Originally thought to be caused by S. aureus and treated with oral bacitracin • Stool cultures routinely ordered for S. aureus • Early 1970’s, a new explanation • “Clindamycin Colitis” • Severe diarrhea, pseudomembrane colitis, and occasional deaths documented in patients on clindamycin

  4. CDI Overview • Spore-forming, anaerobic, gram-positive bacterium • Causes gastrointestinal infections resulting in diarrhea and colitis • – Severity ranges from mild colitis to toxic megacolon and death • Leading cause of healthcare-associated infectious diarrhea in US • Rivals methicillin-resistant Staphylococcus aureus (MRSA) as the most common organism to cause healthcare-associated infections in US

  5. Prevalence • C. difficile causes about 500,000 illnesses in the United States every year (Kuchn, 2011). • In the United States, estimated 15000-20000 patients die from the illness each year (Barbut, Jones, & Eckert, 2011). • In the general population, one to three percent of adults are colonized with the organism (Barbut et al., 2011). However, about 20 percent of hospitalized adults are C. difficile carriers (LaMont, 2009).

  6. Strains of C. difficile • Anaerobic, gram-positive, spore-forming, bacillus • Non-toxin producing C. difficile • Toxin A (tcdA) • Toxin B (tcdB) • NAP1/BI/027 (deletion tcdC) • Down regulation of toxin production • Enhance capability for production of toxin A and B.

  7. NAP1/BI/027 (deletion tcdC)

  8. Pathogenesis

  9. Two forms of C. difficile Vegetative Spore

  10. Crypts

  11. Normal vs. compromised

  12. Pathogenesis cont.

  13. Toxin effects on colon

  14. Pseudomembranes

  15. Clinical Symptoms • Watery diarrhea is the cardinal clinical symptoms • Diarrhea can be up to 15 times per day • Fever, cramping, abdominal discomfort, and peripheral leukocytosis (cohen, 2010) • Colonic ileus or toxic dilatation may present with no or minimal diarrhea.

  16. Methods of testing C. difficile • Culture • Cell cytotoxicity neutralization assay • Enzyme immunoassays (EIA) C. difficiletoxin A (Tcd A) • EIA TcdB or TcdA/B • EIA, glutamate dehydrogenase (GDH) • Nucleic acid amplification tests

  17. Culture • Target: organism • Advantages: • High sensitivity (often considered as the gold standard) • Disadvantages: • Turn-around time >7 days • Labor intensive • Lacks specificity • Isolates must be further tested for the presence of toxins

  18. Cell cytotoxinneutrlization assay • Functional assay for C. difficiletoxin B (TcdB) • Advantages: • Moderate-to-high sensitivity • High specificity • Disadvantages: • 48-72 hrs turn-around time • Subjective interpretation • Labor intensive

  19. Enzyme immunoassays (EIA) C. difficiletoxin A (Tcd A) • Target: Toxin A detection • Advantages: • Easy to perform • Rapid turn-around time • Inexpensive • High specificity • Disadvantages: • Low sensitivity • MissessTcdA-/TcdB+ isolates

  20. EIA TcdB or TcdA/B • Target: Toxin A or B detection • Advantages: • Easy to perform • Rapid turn-around time • Inexpensive • High specificity • Disadvantages: • Low sensitivity

  21. EIA, glutamate dehydrogenase (GDH) • Method: common antigen detection • Advantages: • High sensitivity • Good screening test • Disadvantages: • Low specificity • Must test further

  22. Nucleic acid amplification tests • Method: Toxin gene detection • Advantages: • High sensitivity • High specificity • Short-turn around time • Easy to perform, minimal hands on • Disadvantages: • Expensive • Detection of asymptomatic colonization

  23. Combination method and algorithm Report as negative Report as positive Need further testing

  24. Combination method and algorithm Report as positive Report as negative

  25. 46 Consequences of Bad Tests • Repeat testing • Low sensitivity • – False negative patients don’t get treated and spread the organism • Low specificity • – False positive patients get costly treatments and IC protocols

  26. Practice change • Send stool to lab right away or refrigerate If GDH and EIA method are used • Test only symptomatic patient (3 loose stools in 24 hours) • Test only loose stool (stick or conform) • Test only one stool per patient per week • Do not test for cure • Assess patient for other reasons for the diarrhea

  27. Clinical Practice Guidelines 2010 SHEA and IDSA Summary • Test only unformed stool (exception: ileus) • Do not perform a test of cure • Stool cultures sensitive but not practical except for epidemiological studies • EIA is rapid, not very sensitive and is sub-optimal • 2 step GDH and EIA is a interim recommendation • More data needed on PCR before they can recommend • Repeat testing discouraged Cohen, S.H. et al. 2010. ICHE. 31: 431-455

  28. Transmission of C. difficile • Person to person by swallowing fecal matter. • Periods between exposure C. difficileand the occurrences 2- 3 days (cohen, 2010) • Culprits in healthcare: • Contaminated hands of healthcare worker • Electronic rectal thermometers • Inadequately cleaned commodes or bedpans

  29. Germs (skin bacteria) Culture plate showing growth of germs 24 hours after a nurse placed her hand on the plate

  30. Before entering the room,Clean your hands with: OR Soap and Water Hand Sanitizer

  31. After Leaving the room:Wash with soap and water only

  32. Environmental source • Acquisition of spores on gloved hands occurred as frequently after contact with environmental surfaces as after contact with skin sites (50% vs50%)

  33. Portable equipment • Electronic thermometers • Blood pressure cuffs • Bedside commodes • Stethoscopes Cohen SH, et al. ICHE 2010;31:31:431-55

  34. Confusing products • Omit confusing products

  35. Confusion about who cleans what • House keeping ? • Nurses? • Central supply? • Nobody?

  36. Sufficient contact time is necessary Barbut F, et al. Infect Control HospEpidemiol 2009;30:507-14

  37. Stopping the spread: Cleaning and Disinfection Cleaning: Removal of organic matter and visible dirt Disinfection: Killing of microorganisms

  38. Reducing contamination of cleaning solution and cleaning tools • Laundering microfiber/swiffer after each room cleaning. • Replace soiled microfiber/swiffer with clean item each time a bucket or detergent/disinfectant is emptied or replaced. • Keeping microfibers/swiffers in solutions do not kill all the bugs, some bugs can grow in the solution. • Make sufficient cleaning solution for the day, emptying the solution and drying out the container minimize contamination. Clostridium difficile Excerpt: Guideline for Environmental Infection Control in Health-Care Facilities, 2003

  39. High-touch surfaces Huslage K, et al. A quantitative approach to defining high-touch surfaces in hospitals. Infect Control HospEpidemiol 2010;31:850-3.

  40. Identify frequently touched surfaces

  41. Monitor Cleaning

  42. Daily Cleaning • Wipe all high-touch surface daily • Two wipe system, Clean and Disinfect • Minimizing mist and aerosol dispersion

  43. One bleach wipe multiple time vs. fresh one each time

  44. Terminal/ Dischrage Cleaning • Clean all high-touch surfaces and all other area including wall with quaternary solution • Then disinfect with bleach wipe or bleach solution. • Stay wet for 10 minutes

  45. Quatvs Bleach

  46. Diluted bleach Diluted bleach only stable only for 24 hrs

  47. Peroxyacetic acid/ hydrogen peroxide/ Octanoic acid combination • One- Step detergent disinfectant • Components: • Peroxyacetic acid 0.05% • Hydrogen peroxide 3.13% • Octanoic acid 0.099% • Kills C. difficilespores in 10 minutes • Effective with 5% organic load (peracetic acid is not affected as much as bleech by organic load) • Compatible with materials

  48. Peroxyacetic acid/ hydrogen peroxide/ Octanoic acid combination • Precautionary Statement: • Danger: Causes irreversible eye damage. Do not get in eyes or on clothing. Wear goggles, face shield, or shielded safety glasses.

  49. Hydrogen peroxide mist

More Related